Guy Chouinard
Guy Chouinard
professor of psychiatry and medicine
Bestätigte E-Mail-Adresse bei umontreal.ca
TitelZitiert vonJahr
Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT)
HY Meltzer, L Alphs, AI Green, AC Altamura, R Anand, A Bertoldi, ...
Archives of general psychiatry 60 (1), 82-91, 2003
12492003
A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
G Chouinard, B Jones, G Remington, D Bloom, D Addington, ...
Journal of clinical psychopharmacology, 1993
10921993
The extrapyramidal symptoms rating scale
G Chouinard
Can. J. Neurol. Sci. 7, 233-244, 1980
7671980
The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.
SR Marder, JM Davis, G Chouinard
The Journal of clinical psychiatry, 1997
7381997
Placebo-controlled study of gabapentin treatment of panic disorder
AC Pande, MH Pollack, J Crockatt, M Greiner, G Chouinard, RB Lydiard, ...
Journal of clinical psychopharmacology 20 (4), 467-471, 2000
3712000
Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics
G Chouinard, BD Jones
Am J Psychiatry 137 (1), 16-21, 1980
3681980
Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder
J Greist, G Chouinard, E DuBoff, A Halaris, SW Kim, L Koran, M Liebowitz, ...
Archives of General Psychiatry 52 (4), 289-295, 1995
3511995
Manual for the extrapyramidal symptom rating scale (ESRS)
G Chouinard, HC Margolese
Schizophrenia research 76 (2-3), 247-265, 2005
3272005
Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.
G Chouinard
The journal of clinical psychiatry 65, 7-12, 2004
3172004
Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients.
AM Ghadirian, G Chouinard, L Annable
Journal of Nervous and Mental Disease, 1982
3081982
Antidepressant efficacy of sertraline: a double-blind, placebo-and amitriptyline-controlled, multicenter comparison study in outpatients with major depression.
FW Reimherr, G Chouinard, CK Cohn, JO Cole, TM Itil, YD LaPierre, ...
The Journal of clinical psychiatry, 1990
3011990
Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study
G Chouinard, L Annable, R Fontaine, L Solyom
Psychopharmacology 77 (3), 229-233, 1982
2951982
Antimanic effect of clonazepam.
G Chouinard, SN Young, L Annable
Biological psychiatry 18 (4), 451-466, 1983
2481983
Neuroleptic-induced supersensitivity psychosis.
G Chouinard, BD Jones, L Annable
The American journal of psychiatry, 1978
2291978
Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial
Y Dion, L Annable, P Sandor, G Chouinard
Journal of clinical psychopharmacology 22 (1), 31-39, 2002
2202002
Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment
R Fontaine, G Chouinard, L Annable
Am J Psychiatry 141 (7), 848-852, 1984
2191984
Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.
G Chouinard, W Goodman, J Greist, M Jenike, S Rasmussen, K White, ...
Psychopharmacology Bulletin, 1990
2141990
A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients
HJ Möller, H Müller, RL Borison, NR Schooler, G Chouinard
European archives of psychiatry and clinical neuroscience 245 (1), 45-49, 1995
1931995
A comparison of venlafaxine, trazodone, and placebo in major depression.
LA Cunningham, RL Borison, JS Carman, G Chouinard, JE Crowder, ...
Journal of clinical psychopharmacology, 1994
1871994
A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder
A Halaris, SW Kimº, L Koranº, MR Liebowtiz, B Lydiardº, S McElroyº
International clinical psychopharmacology 10, 57-65, 1995
1851995
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20